Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Oncoimmunology|January 27, 2017
Peripheral blood Th9 cells are a possible pharmacodynamic biomarker of nivolumab treatment efficacy in metastatic melanoma patientsYumi Nonomura, Atsushi Otsuka, Chisa Nakashima, et al.
The Journal of Dermatology|April 11, 2020
Vitiligo expansion and extent correlate with durable response in anti-programmed death 1 antibody treatment for advanced melanoma: A multi-institutional retrospective studyTaisuke Matsuya, Yasuhiro Nakamura, Shigeto Matsushita, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 16, 2022
Knapperer Resektionsrand bei Plattenepithelkarzinomen mit hohem oder sehr hohem Risiko: eine retrospektive multizentrische Studie mit 1000 PatientenNatsuki Baba, Hiroshi Kato, Motoki Nakamura, et al.
Oncotarget|April 13, 2018
Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot studyTaku Fujimura, Yota Sato, Kayo Tanita, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 4, 2022
Narrower clinical margin in high or very high-risk squamous cell carcinoma: a retrospective, multicenter study of 1,000 patientsNatsuki Baba, Hiroshi Kato, Motoki Nakamura, et al.
Experimental Dermatology|July 3, 2023
Evaluation of prognostic prediction ability of the novel Japanese risk factor scoring system in a Japanese cohort of resectable cutaneous squamous cell carcinoma: A retrospective cross-sectional studyReiichi Doi, Natsuki Baba, Hiroshi Kato, et al.
Frontiers in Oncology|December 5, 2018
Serum Level of Soluble CD163 May Be a Predictive Marker of the Effectiveness of Nivolumab in Patients With Advanced Cutaneous MelanomaTaku Fujimura, Yota Sato, Kayo Tanita, et al.
The Journal of Dermatology|July 7, 2026
Efficacy of Adjuvant Interferon-β Versus Observation for Resected Nail Apparatus Melanoma: A Multicenter Retrospective StudyTakaya Komori, Eiji Nakano, Yukiko Kiniwa, et al.
The Journal of Dermatology|May 5, 2022
Concordance in judgment of clinical borders of basal cell carcinomas in Japanese patients: A preliminary study of JCOG2005 (J-BASE-MARGIN)Anna Kamimura, Yasuhiro Nakamura, Tatsuya Takenouchi, et al.
Pageof 3